TL

Thomas Lynch Portfolio

Invests via QVIDTVM Management LLC | Managed by Burak Alici, Thomas Lynch
Invests via QVIDTVM Management LLC
Managed by Burak Alici, Thomas Lynch
Automatically Tracked
Tracking: 0 Updated: 4 hours ago
Thomas Lynch Profile

With a strong background in corporate finance and operational leadership, Thomas Lynch has carved out a significant role within the financial services industry. His expertise encompasses mergers and acquisitions, strategic planning, and business development. Over the years, he has held key positions in several prominent organizations where he led transformative initiatives that drove growth and enhanced profitability. Known for his keen insights into market dynamics, he actively engages with investment firms seeking to identify new opportunities within evolving sectors. Through this proactive involvement in both executive management and advisory capacities, Lynch continues to influence trends across various segments of capital markets.

With a strong background in corporate finance and operational leadership, Thomas Lynch has carved out a significant role within the financial services industry. His expertise encompasses mergers and acquisitions, strategic planning, and business development. Over the years, he has held key positions in several prominent organizations where he led transformative initiatives that drove growth and enhanced profitability. Known for his keen insights into market dynamics, he actively engages with investment firms seeking to identify new opportunities within evolving sectors. Through this proactive involvement in both executive management and advisory capacities, Lynch continues to influence trends across various segments of capital markets.

Investment Philosophy & Strategy

A market-centric perspective shapes Thomas Lynch's approach to investment, as he emphasizes identifying transformative opportunities across dynamic sectors. Drawing from a robust foundation in corporate finance and strategic leadership, he pursues investments that exhibit significant growth potential through operational enhancements. His keen understanding of market trends informs a tactical selection process aimed at maximizing value creation for stakeholders. By leveraging his extensive experience in mergers and acquisitions, the focus remains on initiatives that can disrupt existing paradigms while delivering sustainable returns.

A market-centric perspective shapes Thomas Lynch's approach to investment, as he emphasizes identifying transformative opportunities across dynamic sectors. Drawing from a robust foundation in corporate finance and strategic leadership, he pursues investments that exhibit significant growth potential through operational enhancements. His keen understanding of market trends informs a tactical selection process aimed at maximizing value creation for stakeholders. By leveraging his extensive experience in mergers and acquisitions, the focus remains on initiatives that can disrupt existing paradigms while delivering sustainable returns.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
-5.28%
Gain +0.38%
Monthly
0%
Yearly
0.04%
Drawdown
34.84%
$84.2M
Equity
Holdings
$84.2M
Investment
$94.48M
$7.93M
Profit +$246,345.66
Realized
$18.2M
Unrealized
-$10.27M
Dividends
$2.1M

Goals

Avg. 25.5% completed goals
Yearly
Gain > 5%
2026
0%
Yearly
Gain < 20%
2026
51%
Today
Compared To Yesterday
Gain
0.38%
Profit
$246,345.66
Win %
51%
This Week
Compared To Last Week
Gain
0.52%
Profit
$438,421.82
Win %
51%
This Month
Compared to last month
Gain
-3.99%
Profit
-$3.5M
Win %
51%
This Year
Compared to last year
Gain
-9.73%
Profit
-$7.42M
Win %
51%
Dentsply Sirona Inc. logo
XRAY Dentsply Sirona Inc.
+3.7%
+$144,528.37
Amrize Ltd. logo
AMRZ Amrize Ltd.
+2.81%
+$330,533.12
Wabtec Corporation logo
WAB Wabtec Corporation
+1.61%
+$11,966.4
Philip Morris International Inc. logo
PM Philip Morris International Inc.
+1.01%
+$1,985.36
Bio-Rad Laboratories Inc. logo
BIO Bio-Rad Laboratories Inc.
+0.86%
+$208,492.68
BRC Inc. logo
BRCC BRC Inc.
0%
$0
Fluidigm Corp logo
FLDM Fluidigm Corp
0%
$0
H&R Block Inc. logo
HRB H&R Block Inc.
0%
$0
Rentokil Initial Plc logo
RTOKY Rentokil Initial Plc
0%
$0
Yandex NV logo
YNDX Yandex NV
0%
$0
Ermenegildo Zegna N.V. logo
ZGN Ermenegildo Zegna N.V.
-2.1%
-$163,026.83
Oracle Corporation logo
ORCL Oracle Corporation
-1.57%
-$117,484.04
Alexandria Real Estate Equities, Inc. logo
ARE Alexandria Real Estate Equities, Inc.
-1.47%
-$30,800
Solventum Corporation logo
SOLV Solventum Corporation
-0.75%
-$152,728.62
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
124
Longs Won
71/124 57%
Profit Factor
1.21
Profitability
Shorts Won
0/0 0%
Standard Deviation
$1.46M
Average Win
$649,292.01
Best Trade
(Dec 31) $7.38M
Sharpe Ratio
-49.14
Average Loss
-$720,190.5
Worst Trade
(Jun 15) -$5.89M
Z-Score
-0.77 (56.03%)
Commissions
$0
Avg. Trade Length
1y 2m 1d
Expectancy
$63,948.68
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% 0.03% 0.24% 1.01% 3.1% 7.73% 16.74% 32.69% 58.98%
Consecutive Losing Trades 117 105 94 82 70 58 47 35 23 12
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV